Biblio

Export 1476 results:
Author [ Title(Asc)] Type Year
Filters: First Letter Of Last Name is K  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
M. Brendel, Sauerbeck, J., Greven, S., Kotz, S., Scheiwein, F., Blautzik, J., Delker, A., Pogarell, O., Ishii, K., Bartenstein, P., and Rominger, A., Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms., J Alzheimers Dis, vol. 65, no. 3, pp. 793-806, 2018.
G. S. Smith, Kuwabara, H., Yan, H., Nassery, N., Yoon, M., Kamath, V., Kraut, M., Gould, N. F., Savonenko, A., Coughlin, J. M., Lodge, M., Pomper, M. G., Nandi, A., Holt, D., Dannals, R. F., and Leoutsakos, J. M., Serotonin Degeneration and Amyloid-β Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits., J Alzheimers Dis, vol. 96, no. 1, pp. 215-227, 2023.
G. S. Smith, Kuwabara, H., Yan, H., Nassery, N., Yoon, M., Kamath, V., Kraut, M., Gould, N. F., Savonenko, A., Coughlin, J. M., Lodge, M., Pomper, M. G., Nandi, A., Holt, D., Dannals, R. F., and Leoutsakos, J. M., Serotonin Degeneration and Amyloid-β Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits., J Alzheimers Dis, vol. 96, no. 1, pp. 215-227, 2023.
G. S. Smith, Kuwabara, H., Yan, H., Nassery, N., Yoon, M., Kamath, V., Kraut, M., Gould, N. F., Savonenko, A., Coughlin, J. M., Lodge, M., Pomper, M. G., Nandi, A., Holt, D., Dannals, R. F., and Leoutsakos, J. M., Serotonin Degeneration and Amyloid-β Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits., J Alzheimers Dis, vol. 96, no. 1, pp. 215-227, 2023.
I. Yasue, Matsunaga, S., Kishi, T., Fujita, K., and Iwata, N., Serotonin 2A Receptor Inverse Agonist as a Treatment for Parkinson's Disease Psychosis: A Systematic Review and Meta-analysis of Serotonin 2A Receptor Negative Modulators., J Alzheimers Dis, vol. 50, no. 3, pp. 733-40, 2016.
S. Klöppel, Kotschi, M., Peter, J., Egger, K., Hausner, L., Frölich, L., Förster, A., Heimbach, B., Normann, C., Vach, W., Urbach, H., and Abdulkadir, A., Separating Symptomatic Alzheimer's Disease from Depression based on Structural MRI., J Alzheimers Dis, vol. 63, no. 1, pp. 353-363, 2018.
S. Klöppel, Kotschi, M., Peter, J., Egger, K., Hausner, L., Frölich, L., Förster, A., Heimbach, B., Normann, C., Vach, W., Urbach, H., and Abdulkadir, A., Separating Symptomatic Alzheimer's Disease from Depression based on Structural MRI., J Alzheimers Dis, vol. 63, no. 1, pp. 353-363, 2018.
M. - N. Vercambre, Okereke, O. I., Kawachi, I., Grodstein, F., and Kang, J. H., Self-Reported Change in Quality of Life with Retirement and Later Cognitive Decline: Prospective Data from the Nurses' Health Study., J Alzheimers Dis, vol. 52, no. 3, pp. 887-98, 2016.
M. - N. Vercambre, Okereke, O. I., Kawachi, I., Grodstein, F., and Kang, J. H., Self-Reported Change in Quality of Life with Retirement and Later Cognitive Decline: Prospective Data from the Nurses' Health Study., J Alzheimers Dis, vol. 52, no. 3, pp. 887-98, 2016.
L. Vaskivuo, Hokkanen, L., Hänninen, T., Antikainen, R., Bäckman, L., Laatikainen, T., Paajanen, T., Stigsdotter-Neely, A., Strandberg, T., Tuomilehto, J., Soininen, H., Kivipelto, M., and Ngandu, T., Self and Informant Memory Reports in FINGER: Associations with Two-Year Cognitive Change., J Alzheimers Dis, vol. 71, no. 3, pp. 785-795, 2019.
R. H. L. H. Rueli, Torres, D. J., Dewing, A. S. T., Kiyohara, A. C., Barayuga, S. M., Bellinger, M. T., Uyehara-Lock, J. H., White, L. R., Moreira, P. I., Berry, M. J., Perry, G., and Bellinger, F. P., Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology., J Alzheimers Dis, vol. 55, no. 2, pp. 749-762, 2017.
B. R. Cardoso, Hare, D. J., Bush, A. I., Li, Q. - X., Fowler, C. J., Masters, C. L., Martins, R. N., Ganio, K., Lothian, A., Mukherjee, S., Kapp, E. A., and Roberts, B. R., Selenium Levels in Serum, Red Blood Cells, and Cerebrospinal Fluid of Alzheimer's Disease Patients: A Report from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL)., J Alzheimers Dis, vol. 57, no. 1, pp. 183-193, 2017.
N. D. DiProspero, Keator, D. B., Phelan, M., van Erp, T. G. M., Doran, E., Powell, D. K., Van Pelt, K. L., Schmitt, F. A., Head, E., Lott, I. T., and Yassa, M. A., Selective Impairment of Long-Range Default Mode Network Functional Connectivity as a Biomarker for Preclinical Alzheimer's Disease in People with Down Syndrome., J Alzheimers Dis, vol. 85, no. 1, pp. 153-165, 2021.
L. D. Van Mierlo, Wouters, H., Sikkes, S. A. M., van der Flier, W. M., Prins, N. D., Bremer, J. A. E., Koene, T., and Van Hout, H. P. J., Screening for Mild Cognitive Impairment and Dementia with Automated, Anonymous Online and Telephone Cognitive Self-Tests., J Alzheimers Dis, vol. 56, no. 1, pp. 249-259, 2017.
B. - E. Kirsebom, Espenes, R., Waterloo, K., Hessen, E., Johnsen, S. Harald, Bråthen, G., Aarsland, D., and Fladby, T., Screening for Alzheimer's Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients., J Alzheimers Dis, vol. 60, no. 4, pp. 1621-1631, 2017.
M. Fujishima, Kawaguchi, A., Maikusa, N., Kuwano, R., Iwatsubo, T., and Matsuda, H., Sample Size Estimation for Alzheimer's Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging., J Alzheimers Dis, vol. 56, no. 1, pp. 75-88, 2017.
M. Fujishima, Kawaguchi, A., Maikusa, N., Kuwano, R., Iwatsubo, T., and Matsuda, H., Sample Size Estimation for Alzheimer's Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging., J Alzheimers Dis, vol. 56, no. 1, pp. 75-88, 2017.
S. Takenoshita, Terada, S., Yokota, O., Kutoku, Y., Wakutani, Y., Nakashima, M., Maki, Y., Hattori, H., and Yamada, N., Sally-Anne Test in Patients with Alzheimer's Disease Dementia., J Alzheimers Dis, vol. 61, no. 3, pp. 1029-1036, 2018.
M. Pejstrup Agger, Danielsen, E. Rubæk, Carstensen, M. Schultz, N Nguyen, M., Horning, M., Henney, M. Alexander, Jensen, C. Boe Ravn, Baandrup, A. Ohlhues, Kjær, T. Wesenberg, Madsen, K. Hougaard, Miskowiak, K., Petersen, P. Michael, and Høgh, P., Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study., J Alzheimers Dis, vol. 92, no. 2, pp. 653-665, 2023.
V. Leinonen, Rauramaa, T., Johansson, J., Bottelbergs, A., Tesseur, I., van der Ark, P., Pemberton, D., Koivisto, A. M., Jääskeläinen, J. E., Hiltunen, M., Herukka, S. - K., Blennow, K., Zetterberg, H., Jokinen, P., Rokka, J., Helin, S., Haaparanta-Solin, M., Solin, O., Okamura, N., Kolb, H. C., and Rinne, J. O., S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies., J Alzheimers Dis, vol. 64, no. 1, pp. 171-179, 2018.
V. Leinonen, Rauramaa, T., Johansson, J., Bottelbergs, A., Tesseur, I., van der Ark, P., Pemberton, D., Koivisto, A. M., Jääskeläinen, J. E., Hiltunen, M., Herukka, S. - K., Blennow, K., Zetterberg, H., Jokinen, P., Rokka, J., Helin, S., Haaparanta-Solin, M., Solin, O., Okamura, N., Kolb, H. C., and Rinne, J. O., S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies., J Alzheimers Dis, vol. 64, no. 1, pp. 171-179, 2018.

Pages